טוען...

Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer

The ability to consistently detect cell-free tumor-specific DNA in peripheral blood of patients with metastatic breast cancer provides the opportunity to detect changes in tumor burden and to monitor response to treatment. We developed cMethDNA, a quantitative multiplexed methylation-specific PCR as...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Cancer Res
Main Authors:	Fackler, Mary Jo, Bujanda, Zoila Lopez, Umbricht, Christopher, Teo, Wei Wen, Cho, Soonweng, Zhang, Zhe, Visvanathan, Kala, Jeter, Stacie, Argani, Pedram, Wang, Chenguang, Lyman, Jaclyn P., de Brot, Marina, Ingle, James N., Boughey, Judy, McGuire, Kandace, King, Tari A., Carey, Lisa A., Cope, Leslie, Wolff, Antonio C., Sukumar, Saraswati
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2014
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4327879/ https://ncbi.nlm.nih.gov/pubmed/24737128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-3392
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer

פריטים דומים